This is a news story, published by TechCrunch, that relates primarily to Reid Hoffman news.
For more Reid Hoffman news, you can click here:
more Reid Hoffman newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from TechCrunch, you can click here:
more news from TechCrunchOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
LinkedIn founder Reid Hoffman. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest LinkedIn news, drug discovery news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
drug discovery startupTechCrunch
•Health
Health
79% Informative
Reid Hoffman and Siddhartha Mukherjee have co-founded a new AI -powered drug discovery startup.
The company will initially focus on breast cancer, prostate cancer, and lymphoma.
Manas AI has raised $24.6 million in seed funding from Hoffman , General Catalyst, and Greylock .
VR Score
76
Informative language
74
Neutral language
27
Article tone
formal
Language
English
Language complexity
58
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links
